Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom van der Poll

Showing results (281-290 of 774) with videos related to

Pageof 78
Sort By:
Pathogens and Disease|December 19, 2022
Role of Hypoxia-inducible factor 1α in host defense during pneumococcal pneumoniaLiza Pereverzeva, Natasja A Otto, Hessel Peters-Sengers, et al.
The Journal of Infectious Diseases|December 14, 2004
Macrophages play a dual role during pulmonary tuberculosis in miceJaklien C Leemans, Theo Thepen, Sebastiaan Weijer, et al.
European Cytokine Network|December 6, 2003
Effect of IC14, an anti-CD14 antibody, on plasma and cell-associated chemokines during human endotoxemiaDariusz P Olszyna, Annelies Verbon, John P Pribble, et al.
The Journal of Infectious Diseases|July 11, 2020
Association of Myeloid Liver Kinase B1 Depletion With a Reduction in Alveolar Macrophage Numbers and an Impaired Host Defense During Gram-Negative PneumoniaNatasja A Otto, Alex F de Vos, Jeroen W J van Heijst, et al.
Intensive Care Medicine Experimental|May 7, 2021
Sepsis: deriving biological meaning and clinical applications from high-dimensional dataAlex R Schuurman, Tom D Y Reijnders, Robert F J Kullberg, et al.
The Journal of Infection|November 15, 2025
Cytomegalovirus reactivation and the host immune response in patients with sepsisJustin de Brabander, David S Y Ong, Olaf L Cremer, et al.
Molecular Medicine (Cambridge, Mass.)|July 7, 2015
Pharmacological Targeting of Protease-Activated Receptor 2 Affords Protection from Bleomycin-Induced Pulmonary FibrosisCong Lin, Jan von der Thüsen, Joost Daalhuisen, et al.
Critical Care (London, England)|June 22, 2019
Matrix metalloproteinase-8: a useful biomarker to refine the diagnosis of community-acquired pneumonia upon intensive care unit admission?Fabrice Uhel, Brendon P Scicluna, Lonneke A van Vught, et al.
The Journal of Infectious Diseases|January 5, 2002
Roles of interleukin-6 and macrophage inflammatory protein-2 in pneumolysin-induced lung inflammation in miceAnita W Rijneveld, Germie P van den Dobbelsteen, Sandrine Florquin, et al.
Critical Care (London, England)|May 28, 2026
Machine-learning algorithms identifies sTREM1 has a key biomarker for outcome prediction in critically illCharles de Roquetaillade, Pierre-Louis Blot, Fabrice Uhel, et al.
Pageof 78

Showing results (281-290 of 774) with videos related to

Sort By:
Pageof 78
Pathogens and Disease|December 19, 2022
Role of Hypoxia-inducible factor 1α in host defense during pneumococcal pneumoniaLiza Pereverzeva, Natasja A Otto, Hessel Peters-Sengers, et al.
The Journal of Infectious Diseases|December 14, 2004
Macrophages play a dual role during pulmonary tuberculosis in miceJaklien C Leemans, Theo Thepen, Sebastiaan Weijer, et al.
European Cytokine Network|December 6, 2003
Effect of IC14, an anti-CD14 antibody, on plasma and cell-associated chemokines during human endotoxemiaDariusz P Olszyna, Annelies Verbon, John P Pribble, et al.
The Journal of Infectious Diseases|July 11, 2020
Association of Myeloid Liver Kinase B1 Depletion With a Reduction in Alveolar Macrophage Numbers and an Impaired Host Defense During Gram-Negative PneumoniaNatasja A Otto, Alex F de Vos, Jeroen W J van Heijst, et al.
Intensive Care Medicine Experimental|May 7, 2021
Sepsis: deriving biological meaning and clinical applications from high-dimensional dataAlex R Schuurman, Tom D Y Reijnders, Robert F J Kullberg, et al.
The Journal of Infection|November 15, 2025
Cytomegalovirus reactivation and the host immune response in patients with sepsisJustin de Brabander, David S Y Ong, Olaf L Cremer, et al.
Molecular Medicine (Cambridge, Mass.)|July 7, 2015
Pharmacological Targeting of Protease-Activated Receptor 2 Affords Protection from Bleomycin-Induced Pulmonary FibrosisCong Lin, Jan von der Thüsen, Joost Daalhuisen, et al.
Critical Care (London, England)|June 22, 2019
Matrix metalloproteinase-8: a useful biomarker to refine the diagnosis of community-acquired pneumonia upon intensive care unit admission?Fabrice Uhel, Brendon P Scicluna, Lonneke A van Vught, et al.
The Journal of Infectious Diseases|January 5, 2002
Roles of interleukin-6 and macrophage inflammatory protein-2 in pneumolysin-induced lung inflammation in miceAnita W Rijneveld, Germie P van den Dobbelsteen, Sandrine Florquin, et al.
Critical Care (London, England)|May 28, 2026
Machine-learning algorithms identifies sTREM1 has a key biomarker for outcome prediction in critically illCharles de Roquetaillade, Pierre-Louis Blot, Fabrice Uhel, et al.
Pageof 78